Citation Impact
Citing Papers
Phosphorylation of Cell Surface Receptors: A Mechanism for Regulating Signal Transduction Pathways
1988 StandoutNobel
The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure
1996 Standout
Regulation of cellular immune responses by selenium
1992
Selective spider toxins reveal a role for the Nav1.1 channel in mechanical pain
2016 StandoutNatureNobel
Physiological and nutritional importance of selenium
1991
Oxygen Uptake Kinetics and Cardiopulmonary Performance in Lone Atrial Fibrillation and the Effects of Sotalol
1997
Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A−/−, 5-HT1B−/−, 5-HT2A−/−, 5-HT3A−/− and 5-HTT−/− knock-out male mice
2007 StandoutNobel
A Controlled Trial of Selegiline, Alpha-Tocopherol, or Both as Treatment for Alzheimer's Disease
1997 Standout
An Ion Channel Essential for Sensing Chemical Damage
2007 StandoutNobel
Effect of Prolonged Nerve Block on Inflammatory Hyperalgesia in Rats
1998
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection
1990
Selenium and human health
2012 Standout
The importance of selenium to human health
2000 Standout
Modified formalin test: characteristic biphasic pain response
1989 Standout
Clinician’s Guide to Cardiopulmonary Exercise Testing in Adults
2010 Standout
Supplementation with selenium and human immune cell functions
1994
The formalin test: an evaluation of the method
1992 Standout
The biopsychosocial approach to chronic pain: Scientific advances and future directions.
2007 Standout
Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta-blocking agents
1993
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
2009 Standout
The Free Radical Theory of Aging
2003
Some Aspects of the Biological Role of Adenosine 3',5'-monophosphate (Cyclic AMP)
1968 StandoutNobel
Noradrenaline binding and the search for catecholamine receptors
1974 Nature
Identification of alpha-adrenergic receptors in uterine smooth muscle membranes by [3H]dihydroergocryptine binding.
1976 StandoutNobel
Blockade by WB 4101 of α-adrenoceptors in the rat vas deferens and guinea-pig taenia caeci
1978
Alpha-Adrenergic Receptor Subtypes
1980 StandoutNobel
Hemolytic Plaque Formation by Leukocytes in Vitro CONTROL BY VASOACTIVE HORMONES
1974
Selectivity in Beta-Adrenergic Responses
1974 StandoutNobel
Azole-Based Energetic Salts
2011 Standout
β-adrenergic receptors: Stereospecificity and lack of affinity for catechols
1974
The Free Radical Theory of Aging Matures
1998 Standout
Bioisosterism: A Rational Approach in Drug Design
1996
beta-Adrenergic regulation of insulin and epidermal growth factor receptors in rat adipocytes.
1983
Regulation of transmembrane signaling by receptor phosphorylation
1987 StandoutNobel
Alpha-Adrenergic Receptor Identification by [ 3 H]Dihydroergocryptine Binding
1976 StandoutScienceNobel
The 5-HT3Subtype of Serotonin Receptor Contributes to Nociceptive Processing via a Novel Subset of Myelinated and Unmyelinated Nociceptors
2002 StandoutNobel
CYCLIC AMP MEDIATION OF NOREPINEPHRINE INHIBITION IN RAT CEREBELLAR CORTEX: A UNIQUE CLASS OF SYNAPTIC RESPONSES
1971
Direct identification and characterisation of β-adrenergic receptors in rat brain
1975 StandoutNatureNobel
Heterogeneity of radioligand binding to alpha-adrenergic receptors. Analysis of guanine nucleotide regulation of agonist binding in relation to receptor subtypes.
1980 StandoutNobel
Binding of (125I)iodohydroxybenzylpindolol to putative beta-adrenergic receptors of rat glioma cells and other cell clones.
1976 StandoutNobel
Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis
1971
MEDIATION OF IMMUNOLOGIC DISCHARGE OF LYSOSOMAL ENZYMES FROM HUMAN NEUTROPHILS BY GUANOSINE 3',5'-MONOPHOSPHATE
1974 StandoutNobel
ADRENERGIC RECEPTORS IN THE MYOMETRIUM
1967
In Vitro Desensitization of Beta Adrenergic Receptors in Human Neutrophils. ATTENUATION BY CORTICOSTEROIDS
1983 StandoutNobel
Pharmacological Properties of H 56/28—a ß‐Adrenergic Receptor Antagonist
1967
Environmental fate of explosives
2002
AUTONOMIC CONTROL OF METABOLISM*
1967
Fluorine in Pharmaceuticals: Looking Beyond Intuition
2007 StandoutScience
Tachyphylaxis to inhaled isoproterenol and the effect of methylprednisolone in dogs
1980
Adipocyte beta-adrenergic receptors. Identification and subcellular localization by (-)-[3H]dihydroalprenolol binding.
1976 StandoutNobel
2-Fluoroadenosine 3':5'-monophosphate. A metabolite of 2-fluoroadenosine in mouse cytotoxic lymphocytes.
1976 StandoutNobel
Modulation of Inflammation and Immunity by Cyclic AMP
1974 Science
Selenium as a risk factor for cardiovascular diseases.
1996
[3H]Norepinephrine binding: Unrelated to catechol-o-methyl transferase
1974 StandoutNobel
Hormonal Control of Lysosomal Enzyme Release from Human Neutrophils: Elevation of Cyclic Nucleotide Levels by Autonomic Neurohormones
1974 StandoutNobel
The receptors concerned in the actions of catecholamines on glucose release, membrane potential and ion movements in guinea‐pig liver
1972
TRPA1 mediates formalin-induced pain
2007 StandoutNobel
Expression of Genes for Metabolism of Cyclic Adenosine 3′:5′-Monophosphate in Somatic Cells
1973 StandoutNobel
Growth of a rat neuroblastoma cell line in serum-free supplemented medium.
1979 Standout
THE STRUCTURE‐ACTIVITY RELATIONSHIPS OF BETA ADRENERGIC DRUGS AND BETA ADRENERGIC BLOCKING DRUGS
1967
Chemistry of Biologically Important Synthetic Organoselenium Compounds
2001 Standout
Large-Scale Applications of Transition Metal-Catalyzed Couplings for the Synthesis of Pharmaceuticals
2011 Standout
Identification of cardiac beta-adrenergic receptors by (minus) [3H]alprenolol binding.
1975 StandoutNobel
Acquired tolerance of hepatocellular carcinoma cells to selenium deficiency: a selective survival mechanism?
2003
Studies on the Role of Adenosine 3',5'-Monophosphate in the Hepatic Actions of Glucagon and Catecholamines
1971 StandoutNobel
Enzyme Release from Polymorphonuclear Leukocyte Lysosomes: Regulation by Autonomic Drugs and Cyclic Nucleotides
1973 StandoutScienceNobel
The action of norepinephrine in the rat hippocampus. I. Iontophoretic studies
1974
Process Development of a Novel Anti-Inflammatory Agent. The Regiospecific Bromination of 4‘-Acetylmethanesulfonanilide
1998
Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. III. Evidence for mediation of norepinephrine effects by cyclic 3′, 5′-adenosine monophosphate
1971
Hormonal Control of Neutrophil Lysosomal Enzyme Release: Effect of Epinephrine on Adenosine 3′,5′-Monophosphate
1974 StandoutScienceNobel
HORMONAL CONTROL OF LYSOSOMAL ENZYME RELEASE FROM HUMAN NEUTROPHILS
1974 StandoutNobel
Effects of Catecholamines on Lipid Mobilization
1966
The aging process.
1981 Standout
Stereospecific [3H](−)-alprenolol binding sites, β-adrenergic receptors and adenylate cyclase
1974 StandoutNobel
Identification of beta-adrenergic receptors in human lymphocytes by (-) (3H) alprenolol binding.
1976 StandoutNobel
Catecholamine binding to the beta-adrenergic receptor.
1977 StandoutNobel
Selenium is an essential trace nutrient for growth of WI-38 diploid human fibroblasts.
1976
Solubilization and characterization of the beta-adrenergic receptor binding sites of frog erythrocytes.
1976 StandoutNobel
SELECTIVE BLOCKADE OF ADRENOCEPTIVE BETA RECEPTORS IN THE HEART
1968
Modulation of cyclic AMP metabolism by S-adenosylhomocysteine and S-3-deazaadenosylhomocysteine in mouse lymphocytes.
1980 StandoutNobel
Ageing of Neurospora crassa. I. Evidence for the free radical theory of ageing from studies of a natural-death mutant
1976
Propranolol and morphine
1976 StandoutNobel
ADRENERGIC MECHANISMS IN CARDIAC GLYCOGEN METABOLISM*
1967
Works of P.M. Lish being referenced
Pharmacological and toxicological properties of two new beta-adrenergic receptor antagonists.
1965
STUDIES ON THE ACUTE INFLAMMATORY RESPONSE. I. INVOLVEMENT OF THE CENTRAL NERVOUS SYSTEM IN CERTAIN MODELS OF INFLAMMATION
1968
PHARMACOLOGIC POTENCY AND SELECTIVITY OF A NEW BRONCHODILATOR AGENT: SOTERENOL (MJ 1992)
1968
EFFECT OF SOME NEW β-ADRENERGIC BLOCKING AGENTS ON CERTAIN METABOLIC RESPONSES TO CATECHOLAMINES
1965
Six month oral toxicity study of trinitrotoluene in beagle dogs
1990
PHARMACOLOGICAL AND TOXICOLOGICAL PROPERTIES OF TWO NEW β-ADRENERGIC RECEPTOR ANTAGONISTS
1965
Cardiac Effects of Sodium Selenite
1975
Effect of some new beta-adrenergic blocking agents on certain metabolic responses to catecholamines.
1965
Amidephrine-II: Cardiovascular actions of a new sympathomimetic amine
1965
Efficacy of a new bronchodilator, soterenol, on experimental locked-lung syndrome in dogs
1968
Selenium in Biology
1975
Sulfonanilides. II. Analogs of Catecholamines
1967
Amidephrine-I: Pharmacologic characterization of a sympathomimetic alkylsulfonamidophenethanolamine
1965
A New Bio-isostere : Alkylsulphonamidophenethanolamines
1964 Nature
Interaction of beta Adrenergic Blockade and Certain Vasodilators in Dextran-Induced Rat Paw Edema
1966